Pathway ID | hsa05323 |
Pathway Term | Rheumatoid arthritis |
Pathway Source | KEGG |
Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
---|---|---|---|---|
TCIRG1 |
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3 |
10312 |
Q13488 |
chr11: 68,039,016-68,050,895 |
TNFSF13B |
tumor necrosis factor superfamily member 13b |
10673 |
Q9Y275 |
chr13: 108,251,240-108,308,484 |
CTSK |
cathepsin K |
1513 |
P43235 |
chr1: 150,796,208-150,808,323 |
CTSL |
cathepsin L |
1514 |
P07711 |
chr9: 87,725,519-87,731,393 |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
2353 |
P01100 |
chr14: 75,278,774-75,282,230 |
ATP6V1C2 |
ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2 |
245973 |
Q8NEY4 |
chr2: 10,721,649-10,785,110 |
ANGPT1 |
angiopoietin 1 |
284 |
Q15389 |
chr8: 107,249,482-107,498,055 |
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
2919 |
P09341 |
chr4: 73,869,393-73,871,242 |
HLA-DMA |
major histocompatibility complex, class II, DM alpha |
3108 |
P28067 |
chr6: 32,948,613-32,969,094 |
HLA-DMB |
major histocompatibility complex, class II, DM beta |
3109 |
P28068 |
chr6: 32,934,629-32,941,070 |
HLA-DOB |
major histocompatibility complex, class II, DO beta |
3112 |
P13765 |
chr6: 32,812,763-32,817,048 |
HLA-DPA1 |
major histocompatibility complex, class II, DP alpha 1 |
3113 |
P20036 |
chr6: 33,064,569-33,080,775 |
HLA-DQA1 |
major histocompatibility complex, class II, DQ alpha 1 |
3117 |
P01909 |
chr6: 32,628,179-32,647,062 |
HLA-DQA2 |
major histocompatibility complex, class II, DQ alpha 2 |
3118 |
P01906 |
chr6: 32,741,342-32,747,215 |
HLA-DQB1 |
major histocompatibility complex, class II, DQ beta 1 |
3119 |
P01920 |
chr6: 32,659,467-32,668,383 |
HLA-DRA |
major histocompatibility complex, class II, DR alpha |
3122 |
P01903 |
chr6: 32,439,842-32,445,046 |
HLA-DRB1 |
major histocompatibility complex, class II, DR beta 1 |
3123 |
P04229 |
chr6: 32,578,769-32,589,848 |
HLA-DRB3 |
major histocompatibility complex, class II, DR beta 3 |
3125 |
P79483 |
chr6: 32,444,128-32,457,245 |
HLA-DRB4 |
major histocompatibility complex, class II, DR beta 4 |
3126 |
P13762 |
chr6: 32,542,598-32,557,561 |
HLA-DRB5 |
major histocompatibility complex, class II, DR beta 5 |
3127 |
Q30154 |
chr6: 32,517,343-32,530,287 |
ICAM1 |
intercellular adhesion molecule 1 |
3383 |
P05362 |
chr19: 10,270,835-10,286,615 |
IL1A |
interleukin 1 alpha |
3552 |
P01583 |
chr2: 112,773,915-112,784,590 |
IL1B |
interleukin 1 beta |
3553 |
P01584 |
chr2: 112,829,751-112,836,903 |
IL6 |
interleukin 6 |
3569 |
P05231 |
chr7: 22,725,884-22,732,002 |
CXCL8 |
chemokine (C-X-C motif) ligand 8 |
3576 |
P10145 |
chr4: 73,740,506-73,743,716 |
IL11 |
interleukin 11 |
3589 |
P20809 |
chr19: 55,364,389-55,370,463 |
IL18 |
interleukin 18 |
3606 |
Q14116 |
chr11: 112,143,251-112,164,117 |
ITGB2 |
integrin subunit beta 2 |
3689 |
P05107 |
chr21: 44,885,953-44,931,989 |
JUN |
jun proto-oncogene |
3725 |
P05412 |
chr1: 58,780,788-58,784,327 |
MMP1 |
matrix metallopeptidase 1 |
4312 |
P03956 |
chr11: 102,789,920-102,798,160 |
ATP6V1D |
ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D |
51382 |
Q9Y5K8 |
chr14: 67,294,371-67,360,265 |
ATP6V1H |
ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H |
51606 |
Q9UI12 |
chr8: 53,715,557-53,843,558 |
ATP6V1B2 |
ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 |
526 |
P21281 |
chr8: 20,197,367-20,226,819 |
ATP6V1C1 |
ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1 |
528 |
P21283 |
chr8: 103,021,063-103,073,051 |
ATP6V1G2 |
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 |
534 |
O95670 |
chr6: 31,544,462-31,548,427 |
ATP6V0A1 |
ATPase, H+ transporting, lysosomal V0 subunit a1 |
535 |
Q93050 |
chr17: 42,458,844-42,522,611 |
CCL2 |
chemokine (C-C motif) ligand 2 |
6347 |
P13500 |
chr17: 34,255,218-34,257,203 |
CCL3 |
chemokine (C-C motif) ligand 3 |
6348 |
P10147 |
chr17: 36,088,256-36,090,169 |
CCL5 |
chemokine (C-C motif) ligand 5 |
6352 |
P13501 |
chr17: 35,871,491-35,880,793 |
CCL20 |
chemokine (C-C motif) ligand 20 |
6364 |
P78556 |
chr2: 227,813,842-227,817,564 |
CXCL6 |
chemokine (C-X-C motif) ligand 6 |
6372 |
P80162 |
chr4: 73,836,497-73,849,064 |
CXCL5 |
chemokine (C-X-C motif) ligand 5 |
6374 |
P42830 |
chr4: 73,995,642-73,998,779 |
CXCL12 |
chemokine (C-X-C motif) ligand 12 |
6387 |
P48061 |
chr10: 44,370,165-44,386,493 |
TEK |
TEK tyrosine kinase, endothelial |
7010 |
Q02763 |
chr9: 27,109,141-27,230,175 |
TGFB1 |
transforming growth factor beta 1 |
7040 |
P01137 |
chr19: 41,301,587-41,353,911 |
TGFB2 |
transforming growth factor beta 2 |
7042 |
P61812 |
chr1: 218,346,235-218,444,619 |
TLR2 |
toll-like receptor 2 |
7097 |
O60603 |
chr4: 153,701,500-153,705,699 |
TLR4 |
toll-like receptor 4 |
7099 |
O00206 |
chr9: 117,704,332-117,716,871 |
TNF |
tumor necrosis factor |
7124 |
P01375 |
chr6: 31,575,567-31,578,336 |
VEGFA |
vascular endothelial growth factor A |
7422 |
P15692 |
chr6: 43,770,184-43,786,487 |
TNFSF11 |
tumor necrosis factor superfamily member 11 |
8600 |
O14788 |
chr13: 42,562,736-42,608,013 |
TNFSF13 |
tumor necrosis factor superfamily member 13 |
8741 |
O75888 |
chr17: 7,558,292-7,561,608 |
TNFRSF11A |
tumor necrosis factor receptor superfamily member 11a |
8792 |
Q9Y6Q6 |
chr18: 62,325,287-62,391,292 |
ATP6V0E1 |
ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1 |
8992 |
O15342 |
chr5: 172,983,757-173,035,445 |
ATP6V0D1 |
ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 |
9114 |
P61421 |
chr16: 67,438,014-67,481,237 |
ATP6V1F |
ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F |
9296 |
Q16864 |
chr7: 128,862,826-128,865,844 |
CD28 |
CD28 molecule |
940 |
P10747 |
chr2: 203,706,475-203,738,912 |
ATP6V1G1 |
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1 |
9550 |
O75348 |
chr9: 114,587,746-114,598,373 |